SCHEMBL9869970

SCHEMBL9869970

ClC(COCc1ccccn1)CN1CCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.51
WDR77 Q9BQA1 1/20 0.51
GAA P10253 2/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 2/20 0.39
CYP2D6 P10635 1/20 0.39
HIF1A Q16665 1/20 0.39
MAPK1 P28482 1/20 0.38
GRM5 P41594 1/20 0.38
ALDH1A1 P00352 2/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TACR1 P25103 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
LTA4H P09960 1/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9869323 0.84 PRMT5 (0.70) PRMT5WDR77GAAHTTKDM4E
SCHEMBL9838672 0.79 TSHR (0.51) PRMT5WDR77GAAHTTKDM4E
SCHEMBL9869891 0.79 TSHR (0.51) PRMT5WDR77GAAHTTKDM4E
SCHEMBL30972154 0.76 LTA4H (0.54) LTA4HPTGS2
SCHEMBL30972142 0.74 LTA4H (0.52) TSHRLTA4HPTGS2
SCHEMBL7271333 0.72 KDM4E (0.67) KDM4ETSHRCYP2D6HIF1AMAPK1
SCHEMBL11538263 0.71 TSHR (0.68) KDM4ETSHRCYP2D6HIF1AMAPK1
SCHEMBL493397 0.70 HRH1 (0.52) KDM4EALDH1A1RAB9ASMN1; SMN2
SCHEMBL8267907 0.70 GRIN2D (0.49) ALDH1A1CYP1A2CYP2C19KMT2A
SCHEMBL2608863 0.70 ALDH1A1 (0.47) PRMT5WDR77HTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4999361-A Cardiovascular disorders, blood vessel relaxants BOEHRINGER MANNHEIM GMBH (DE) 1991-03-12 US disclosed
EP-0330940-A2 Trisubstituted amines, process for their preparation and pharmaceutical preparations containing these compounds Roche Diagnostics GmbH (DE) 1989-09-06 EP disclosed